内脏脂肪增多可预测克罗恩病术后复发
POCER研究纳入44例克罗恩病切除术后患者,利用腹部横断面影像分析身体组成。无论治疗如何,内脏脂肪组织/身高²超过性别均值1.5倍者18个月时均出现内镜下复发(对照组为47%),相对危险度2.1(95%CI 1.5-3.0,P=0.012)。结论认为内脏脂肪增多是术后内镜下复发的独立危险因素。
要点
- 内脏脂肪组织/身高²超过性别均值1.5倍者18个月内镜下复发风险为对照的2.1倍。
- 腰围与内脏脂肪面积高度相关(ρ=0.840,P<0.001)。
- 低骨骼肌患病率为41%,但未预测内镜下复发。
核心结论
- 内脏脂肪增多是克罗恩病术后内镜下复发的独立危险因素。
- 肌肉减少与炎症生物标志物相关。
- 内脏脂肪组织检测可能有助于术后管理策略中的风险分层。
研究设计与样本
- POCER研究为前瞻性研究,评估预防克罗恩病术后复发的管理策略。
- 受试者在切除所有肉眼可见克罗恩病后入组,随机接受早期内镜检查及可能的治疗升级或标准治疗。
- 主要终点为18个月时的内镜下复发。
- 44例有腹部横断面影像的受试者纳入分析,使用既定技术测量内脏脂肪面积、皮下脂肪面积和骨骼肌面积。
主要发现
- 身体组成参数中变异最大的是内脏脂肪组织。
- 无论治疗如何,所有内脏脂肪组织/身高²超过性别均值1.5倍的受试者18个月时均发生内镜下复发,而其余受试者为47%(相对危险度2.1,95%CI 1.5-3.0,P=0.012)。
- 腰围与内脏脂肪面积高度相关(ρ=0.840,P<0.001)。
- 低骨骼肌普遍存在(占患者的41%),但未预测内镜下复发。
- 四肢骨骼肌指数与粪便钙卫蛋白呈负相关(ρ=0.560,P=0.046)。
临床怎么用
- 原文结论指出内脏脂肪组织检测可能有助于术后管理策略中的风险分层,原文未据此给出具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Excessive visceral adipose tissue has been associated with poorer outcomes in patients with inflammatory bowel disease. AIM: To determine whether body composition is associated with outcome in a prospective study of post-operative Crohn's disease patients. METHODS: The POCER study evaluated management strategies for prevention of post-operative Crohn's disease recurrence; subjects were enrolled after resection of all macroscopic Crohn's disease and were randomised to early endoscopy and possible treatment escalation, or standard care. The primary endpoint was endoscopic recurrence at 18 months. 44 subjects with cross-sectional abdominal imaging were studied, and body composition analysis performed using established techniques to measure visceral adipose tissue area, subcutaneous adipose tissue area, and skeletal muscle area. RESULTS: The body composition parameter with the greatest variance was visceral adipose tissue. Regardless of treatment, all subjects with visceral adipose tissue/height2 >1.5 times the gender-specific mean experienced endoscopic recurrence at 18 months (compared to 47%) [relative risk 2.1, 95% CI 1.5-3.0, P = 0.012]. Waist circumference correlated strongly with visceral adipose tissue area (ρ = 0.840, P < 0.001). Low skeletal muscle was prevalent (41% of patients), but did not predict endoscopic recurrence; however, appendicular skeletal muscle indices correlated inversely with faecal calprotectin (ρ = 0.560, P = 0.046). CONCLUSIONS: Visceral adiposity is an independent risk factor for endoscopic recurrence of Crohn's disease after surgery. Sarcopenia correlates with inflammatory biomarkers. Measures of visceral adipose tissue may help to stratify risk in post-operative management strategies.
引用
- Holt DQ, Moore GT, Strauss BJ, et al. Visceral adiposity predicts post-operative Crohn's disease recurrence. Aliment Pharmacol Ther. 2017. PMID: 28244124. doi:10.1111/apt.14018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。